Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profiling of Dermal Papilla cells isolated from wild type (WT) and Fgfr1/Fgfr2 double mutant mice during anagen (at P14 and P16) was performed by RNA-seq analysis

ABSTRACT: Gene expression profiling of Dermal Papilla cells isolated from wild type (WT) and Fgfr1/Fgfr2 double mutant mice during anagen (at P14 and P16) was performed by RNA-seq analysis

PROVIDER: PRJNA655723 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12403950.fastq.gz	Fastqsanger.gz
	SRR12403951.fastq.gz	Fastqsanger.gz
	SRR12403952.fastq.gz	Fastqsanger.gz
	SRR12403953.fastq.gz	Fastqsanger.gz
	SRR12403954.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Gene expression profiling of Dermal Papilla cells isolated from wild type (WT) and Fgfr1/Fgfr2 double mutant mice during anagen (at P14 and P16) was performed by RNA-seq analysis

Project description:Gene expression analysis revealed that the DP transcriptome is altered in the Fgfr1/Fgfr2 double mutant. At P14 the expression of 188 genes was significantly altered. At P16 the expression of 1082 genes were significantly altered.

2020-08-07 | GSE155837 | GEO

Transcripts identified by microarray analysis that were deregulated in E14.5 Tbx18(cre/+);FGFR1(fl/fl);FGFR2(fl/fl) (Fgfr1/2cDKO) ureters

Project description:Evaluation of the transcriptional changes in E14.5 ureters upon loss of Fgfr1 and Fgfr2 in the ureteric mesenchyme.

2022-09-06 | GSE197369 | GEO

RNA-Seq of human glioblastoma cells with knockdown of FGFR1 or FGFR2

Project description:Human glioblastoma cell lines L0, L1, L2 (Deleyrolle et al. Brain 2010) were transduced with lentivirus vectors expressing scrambled control (shCo), FGFR1 knockdown (shFGFR1), or FGFR2 knockdown (shFGFR2) sequences. Cells were cultured in N2 medium containing EGF and stimulated with FGF2 for 48 hours prior to RNA extraction.

2023-08-29 | E-MTAB-13161 | biostudies-arrayexpress

Transcripts identified by microarray analysis that were deregulated in E15.5+6d Tbx18(cre/+);FGFR1(fl/fl);FGFR2(fl/fl) (Fgfr1/2cDKO) ureter cultures

Project description:Evaluation of the transcriptional changes in E15.5+6d ureter cultures upon loss of Fgfr1 and Fgfr2 in the ureteric mesenchyme.

2022-09-06 | GSE197368 | GEO

Transcripts identified by microarray analysis that were deregulated in E13.5 Pax-2cre;Fgfr1(fl/?);Fgfr2(fl/fl) (Fgfr2cKO) ureters.

Project description:Evaluation of the transcriptional changes in E13.5 ureters upon loss of Fgfr2 (and reduction of Fgfr1) in the ureteric epithelium.

2022-01-04 | GSE178093 | GEO

RNA-Seq of human glioblastoma cells with knockdown of FGFR1 or FGFR2

Project description:RNA-Seq of human glioblastoma cells with knockdown of FGFR1 or FGFR2

| PRJEB64549 | ENA

Transcripts identified by microarray analysis that were deregulated in E14.5 Tbx18(cre/+) FGFR1(fl/fl) FGFR2(fl/fl) (Fgfr1/2cDKO) ureters

Project description:Transcripts identified by microarray analysis that were deregulated in E14.5 Tbx18(cre/+) FGFR1(fl/fl) FGFR2(fl/fl) (Fgfr1/2cDKO) ureters

| PRJNA810042 | ENA

Comparison of P18 mouse epidermis from K5-FGFR1/FGFR2 knockout and wild-type mice

Project description:Comparison of P18 mouse epidermis from K5-FGFR1/FGFR2 knockout and wild-type mice

| PRJNA436568 | ENA

Transcripts identified by microarray analysis that were deregulated in E15.5+6d Tbx18(cre/+) FGFR1(fl/fl) FGFR2(fl/fl) (Fgfr1/2cDKO) ureter cultures

Project description:Transcripts identified by microarray analysis that were deregulated in E15.5+6d Tbx18(cre/+) FGFR1(fl/fl) FGFR2(fl/fl) (Fgfr1/2cDKO) ureter cultures

| PRJNA810041 | ENA

Phosphoproteomics of truncated FGFR2, a clinically actionable oncogene in multiple cancers

Project description:Somatic hotspot mutations and structural amplifications and fusions affecting fibroblast growth factor receptor 2 (FGFR2) occur in multiple cancer types. However, clinical responses to FGFR inhibitors (FGFRi) have remained variable, emphasizing a need to better understand which FGFR2 alterations are oncogenic and targetable. Here we applied transposon-based screening and tumor modelling in mice to uncover truncation of exon (E) 18 of Fgfr2 as a potent driver mutation. Human oncogenomic datasets revealed a diverse set of FGFR2 alterations, including rearrangements (REs), E1-E17 partial amplifications, and E18 nonsense and frameshift mutations, each causing transcription of E18-truncated FGFR2 (FGFR2deltaE18). Somatic modelling in mice and human tumor cell lines using a compendium of FGFR2deltaE18 and full-length variants identified FGFR2deltaE18-truncation as potent single-driver alteration in cancer. Here we show the phosphoproteomic landscape of FGFR2 variants in murine epithelial cell (MEC) lines and mouse tumors. Global (STY) phosphoproteomics using IMAC and phosphotyrosine phosphoproteomics using pTyr IP’s are combined with DIA protein expression data to uncover oncogenic signaling of clinically-relevant FGFR2 variants.

2022-06-06 | PXD031711 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data